FrancophonIA/ELRC3.0 huggingface dataset:
English: Before injecting yourself with Inhixa
Slovenian: Preden si injicirate zdravilo Inhixa
English: Extracorporeal use (in the dialysis circuit).
Slovenian: Izventelesna uporaba (v dializnem obtoku).
English: Frequencies are defined as follows: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to <1/1,000); and very rare (< 1/10,000) or not known (cannot be estimated from available data).
Slovenian: Opredelitev pogostnosti je: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000) in zelo redki (< 1/10.000) ali neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov) Pri vsakem organskem sistemu so neželeni učinki navedeni po padajoči resnosti.
English: • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism (VTE).
Slovenian: • Profilakso venske trombembolične bolezni pri nekirurških bolnikih z akutno boleznijo (npr. z akutnim srčnim popuščanjem, respiratorno insuficienco, hudimi okužbami ali revmatskimi boleznimi) in zmanjšano mobilnostjo, ki imajo povečano tveganje za vensko trombembolijo (VTE).
English: Therefore, for patients on enoxaparin sodium, the PCI was to be performed on enoxaparin sodium (no switch) using the regimen established in previous studies i.e. no additional dosing, if last subcutaneous administration given less than 8 hours before balloon inflation, intravenous bolus of 30 IU/ kg (0.3 mg/kg) enoxaparin sodium, if the last subcutaneous administration given more than 8 hours before balloon inflation.
Slovenian: Zato je morala biti za bolnike na natrijevem enoksaparinatu PKI narejena na natrijevem enoksaparinatu (brez menjave) in po shemi, oblikovani v predhodnih študijah - tj. brez dodatnega odmerjanja, če je bila zadnja subkutana uporaba manj kot 8 ur pred balonskim širjenjem, in intravenski bolus 30 i.e./kg (0,3 mg/kg) natrijevega enoksaparinata, če je bila zadnja subkutana uporaba več kot 8 ur pred balonskim širjenjem.
English: • For acute STEMI, treatment is to be initiated with a single intravenous bolus injection immediately followed by a subcutaneous injection.
Slovenian: • Zdravljenje akutnega STEMI je treba začeti z eno intravensko bolusno injekcijo, ki ji neposredno sledi subkutana injekcija.
English: • Uncommon: Hepatocellular liver injury*
Slovenian: • Občasni: Hepatocelularna okvara jeter*
English: If the last subcutaneous administration was given more than 8 hours before balloon inflation, an intravenous bolus of 30 IU/kg (0.3 mg/kg) enoxaparin sodium should be administered.
Slovenian: Če je bil zadnji subkutani odmerek uporabljen več kot 8 ur pred balonskim širjenjem, je treba dati intravenski bolus 30 i.e./kg (0,3 mg/kg) natrijevega enoksaparinata.
English: Overall list of possible side effects Very common (may affect more than 1 in 10 people)
Slovenian: Celotni seznam možnih neželenih učinkov Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov):
English: After you have had a heart attack
Slovenian: • če imate umetno srčno zaklopko
English: Supplied in packs of 1 and 5 vials.
Slovenian: Pakirano v škatlah po 1 ali 5 vial.
English: • Hypersensitivity to enoxaparin sodium, heparin or its derivatives, including other low molecular weight heparins (LMWH), to benzyl alcohol or any other of the excipients listed in section 6.1;
Slovenian: • Preobčutljivostjo za natrijev enoksaparinat, heparin ali njegove derivate, vključno z nizkomolekularnimi heparini (NMH), na benzilalkohol ali katero koli drugo pomožno snov, navedeno v poglavju 6.1.
English: Immuno-allergic thrombocytopenia β: Platelet increased > 400 G/L
Slovenian: Zelo redki: Imunoalergijska trombocitopeni ja β: Povečanje števila trombocitov > 400 G/l
English: Depending on when you were last given Inhixa, your doctor may decide to give an additional dose of Inhixa before a PCI operation.
Slovenian: Pri bolnikih, ki so jim opravili poseg, imenovan perkutana koronarna intervencija (PKI): Odvisno od tega, kdaj ste nazadnje dobili zdravilo Inhixa, se zdravnik lahko odloči za dodaten odmerek zdravila Inhixa pred PKI.
English: Changing from Inhixa to blood thinners called vitamin-K antagonists (e.g. warfarin) Your doctor will request you perform blood tests called INR and tell you when to stop Inhixa accordingly.
Slovenian: - Prehod z zdravila Inhixa na sredstva za redčenje krvi, imenovana antagonisti vitamina K (npr. varfarin) Zdravnik vam bo naročil, da opravite preiskavo krvi, imenovano INR, in vam bo glede na to povedal, kdaj naj nehate uporabljati zdravilo Inhixa.
English: Prophylaxis in surgical patients
Slovenian: Profilaksa pri kirurških bolnikih
English: Injection site nodules* (inflammatory nodules, which were not cystic enclosure of enoxaparin).
Slovenian: o Vozliči* na mestu injiciranja (vnetni vozliči, ki niso bili cistični skupki enoksaparina).
English: For patients being managed with PCI, an additional intravenous bolus of 30 IU/kg (0.3 mg/kg) is to be administered if last subcutaneous administration was given more than 8 hours before balloon inflation.
Slovenian: Bolniki, zdravljeni s PKI, morajo dobiti dodaten intravenski odmerek 30 i.e./kg (0,3 mg/kg), če je bil zadnji subkutani odmerek uporabljen več kot 8 ur pred balonskim širjenjem.
English: In patients with severe renal impairment (creatinine clearance <30 mL/min), the AUC at steady state is significantly increased on average by 65% after repeated subcutaneous 4,000 IU (40 mg) once daily doses (see sections 4.2 and 4.4).
Slovenian: Pri bolnikih s hudo okvaro ledvic (očistek kreatinina < 30 ml/min) je AUC v stanju dinamičnega ravnovesja bistveno večja, povprečno za 65 % po večkratni subkutani uporabi odmerkov 4.000 i.e. (40 mg) enkrat na dan (glejte poglavji 4.2 in 4.4).
English: After repeated subcutaneous 150 IU/kg (1.5 mg/kg) once daily dosing, mean AUC of anti-Xa activity is marginally higher at steady state in obese healthy volunteers (BMI 30-48 kg/m2) compared to non-obese control subjects, while maximum plasma anti-Xa activity level is not increased.
Slovenian: Po večkratni subkutani uporabi 150 i.e./kg (1,5 mg/kg) enkrat na dan je povprečna AUC aktivnosti antiXa v stanju dinamičnega ravnovesja pri debelih zdravih prostovoljcih (ITM 30-48 kg/m2) malenkostno večja kot pri nedebelih kontrolnih osebah, največja raven aktivnosti anti-Xa v plazmi pa ni povečana.
English: For patients with creatinine clearance [15-30 mL/minute], additional considerations are necessary because elimination of enoxaparin sodium is more prolonged (see section 4.2).
Slovenian: Pri bolnikih z očistkom kreatinina od 15 - 30 ml/min je potreben dodaten preudarek, ker je odstranjevanje natrijevega enoksaparinata dolgotrajnejše (glejte poglavje 4.2).
English: • Stop blood clots from forming in your blood in the following situations: o Before and after an operation o When you have an acute illness and face period of limited mobility o When you have unstable angina (a condition when not enough blood gets to your heart) o After a heart attack
Slovenian: • Ustavitev nastajanja krvnih strdkov v krvi v naslednjih okoliščinah: o Pred operacijami in po njih o Če imate akutno bolezen in vas čaka obdobje omejene možnosti gibanja (mobilnosti) o Če imate nestabilno angino pektoris (motnjo, pri kateri v srce ne pride dovolj krvi) o Po srčnem infarktu Preprečitev nastajanja krvnih strdkov v cevkah dializne naprave (uporablja se pri osebah, ki imajo hude težave z ledvicami).
English: Supplied in packs of 5 vials.
Slovenian: Pakirano v škatlah po 5 vial.
English: 100 IU/kg (1 mg/kg) body weight subcutaneously once daily
Slovenian: 100 i.e. (1 mg/kg) telesne mase subkutano enkrat na dan
English: The incidence of major bleeding at 30 days was significantly higher (p < 0.0001) in the enoxaparin sodium group (2.1%) versus the heparin group (1.4%).
Slovenian: Incidenca večjih krvavitev je bila po 30 dneh v skupini z natrijevim enoksaparinatom značilno večja (2,1 %, p < 0,0001) kot v skupini s heparinom (1,4 %).
English: 9) Drop the used syringe into the sharps container.
Slovenian: 9) Uporabljene injekcijske brizge odložite v zabojnik za ostre predmete.
English: All treated DVT patients with or without PE Total VTE (%)
Slovenian: Vsi zdravljeni bolniki z GVT, s PE ali brez nje Vse VTE (%) Samo GVT (%)
English: Talk to your doctor or pharmacist before using Inhixa if:
Slovenian: Pred uporabo zdravila Inhixa se posvetujte z zdravnikom ali farmacevtom:
English: Solution for injection in multidose vial Clear, colourless to pale yellow solution
Slovenian: raztopina za injiciranje v večodmerni viali Bistra, brezbarvna do bledo rumena raztopina
English: • In moderate risk patients, enoxaparin sodium treatment should be maintained for a minimal period of 7-10 days whatever the recovery status (e.g. mobility).
Slovenian: • Pri bolnikih z zmernim tveganjem je treba zdravljenje z natrijevim enoksaparinatom nadaljevati vsaj še 7 - 10 dni, ne glede na stanje okrevanja (npr. mobilnost).
English: The rate of the 30 day composite endpoint of death, myocardial re-infarction or intracranial haemorrhage (a measure of net clinical benefit) was significantly lower (p < 0.0001) in the enoxaparin sodium group (10.1%) as compared to the heparin group (12.2%), representing a 17% relative risk reduction in favour of treatment with enoxaparin sodium.
Slovenian: Delež sestavljenega opazovanega dogodka smrti, ponovnega miokardnega infarkta ali intrakranialne krvavitve (mera neto klinične koristi) v 30 dneh je bil v skupini z natrijevim enoksaparinatom značilno manjši (10,1 %) kot v skupini s heparinom (12,2 %) (p < 0,0001), kar pomeni 17 % relativno zmanjšanje tveganja v korist zdravljenja z natrijevim enoksaparinatom.
English: Initiate dosing with 75 IU/kg (0.75 mg/kg) subcutaneously every 12 hours (maximum 7,500 IU (75 mg) for each of the first two subcutaneous doses only, followed by 75 IU/kg (0.75 mg/kg) subcutaneous dosing for the remaining doses).
Slovenian: Odmerjanje začnite s 75 i.e./kg (0,75 mg/kg) subkutano na 12 ur (največ 7.500 i.e. (75 mg) za vsakega od prvih dveh subkutanih odmerkov, nato pa 75 i.e./kg (0,75 mg/kg) subkutano za preostale odmerke).
English: • For treatment of unstable angina and NSTEMI, the recommended dose of enoxaparin sodium is 100 IU/kg (1 mg/kg) every 12 hours by subcutaneous injection administered in combination with antiplatelet therapy.
Slovenian: • Za zdravljenje nestabilne angine pektoris in NSTEMI je priporočeni odmerek natrijevega enoksaparinata 100 i.e./kg (1 mg/kg) na 12 ur v subkutani injekciji, dani v kombinaciji z antiagregacijskim zdravljenjem.
English: • In patients at moderate risk of thromboembolism, the recommended dose of enoxaparin sodium is 2,000 IU (20 mg) once daily by subcutaneous injection.
Slovenian: • Za bolnike z zmernim tveganjem za trombembolijo je priporočeni odmerek natrijevega enoksaparinata 2.000 i.e. (20 mg) enkrat na dan v subkutani injekciji.
English: To avoid the possible mixture of enoxaparin sodium with other drugs, the intravenous access chosen should be flushed with a sufficient amount of sodium chloride 9 mg/mL (0.9%) solution for infusion or glucose solution prior to and following the intravenous bolus administration of enoxaparin sodium to clear the port of drug.
Slovenian: Da boste preprečili možno mešanje natrijevega enoksaparinata z drugimi zdravili, morate intravenski dostop sprati z zadostno količino raztopine natrijevega klorida 9 mg/ml (0,9 %) za infundiranje ali raztopine glukoze, in sicer pred dajanjem intravenskega bolusa natrijevega enoksaparinata in po njem, da boste nastavek očistili zdravila.
English: 90 pre-filled syringes
Slovenian: 90 napolnjenih injekcijskih brizg
English: The Inhixa pre-filled syringes are for single dose use only.
Slovenian: Napolnjene injekcijske brizge zdravila Inhixa vsebujejo en sam odmerek.
English: Prophylaxis of venous thromboembolism in medical patients The recommended dose of enoxaparin sodium is 4,000 IU (40 mg) once daily by subcutaneous injection.
Slovenian: Profilaksa venske trombembolije pri nekirurških bolnikih Priporočeni odmerek natrijevega enoksaparinata je 4.000 i.e. (40 mg) enkrat na dan v subkutani injekciji.
English: Inhixa 50,000 IU (500 mg)/5 mL
Slovenian: Inhixa 50.000 i.e. (500 mg)/5 ml
English: Following repeated subcutaneous administration no accumulation takes place.
Slovenian: Po ponavljajoči se subkutani uporabi se zdravilo ne kopiči.
English: Inhixa 30,000 IU (300 mg)/3 mL solution for injection in multidose vial Inhixa 50,000 IU (500 mg)/5 mL solution for injection in multidose vial Inhixa 100,000 IU (1000 mg)/10 mL solution for injection in multidose vial enoxaparin sodium
Slovenian: Inhixa 30.000 i.e. (300 mg)/3 ml raztopina za injiciranje v večodmerni viali Inhixa 50.000 i.e. (500 mg)/5 ml raztopina za injiciranje v večodmerni viali Inhixa 100.000 i.e. (1000 mg)/10 ml raztopina za injiciranje v večodmerni viali natrijev enoksaparinat
English: 10) Drop the used syringe into the sharps container.
Slovenian: 10) Uporabljene injekcijske brizge odložite v zabojnik za ostre predmete.
English: • Acetylsalicylic acid is recommended for all patients without contraindications at an initial oral loading dose of 150-300 mg (in acetylsalicylic acid-naive patients) and a maintenance dose of 75-325 mg/day long-term regardless of treatment strategy.
Slovenian: • Acetilsalicilna kislina je priporočljiva za vse bolnike brez kontraindikacij, in sicer v začetnem peroralnem polnilnem odmerku od 150 do 300 mg (pri bolnikih, ki še niso prejemali acetilsalicilne kisline) in v vzdrževalnem odmerku od 75 - 325 mg/dan dolgoročno, ne glede na strategijo zdravljenja.
English: *p value versus placebo =0.008 #p value versus placebo =0.537
Slovenian: *Vrednost p v primerjavi s placebom = 0,008 #Vrednost p v primerjavi s placebom = 0,537
English: Obese Patients
Slovenian: Debeli bolniki
English: Pregnant women with mechanical prosthetic heart valves The use of enoxaparin sodium for thromboprophylaxis in pregnant women with mechanical prosthetic heart valves has not been adequately studied.
Slovenian: Nosečnice z mehaničnimi protetičnimi srčnimi zaklopkami Uporaba natrijevega enoksaparinata za tromboprofilakso pri nosečnicah z mehaničnimi protetičnimi srčnimi zaklopkami ni ustrezno raziskana.
English: Monitoring of platelet counts
Slovenian: Nadziranje števila trombocitov
English: • Proximal DVT
Slovenian: Proksimalne GVT
English: Inhixa 15,000 IU (150 mg)/ mL
Slovenian: Inhixa 15.000 i.e. (150 mg)/ ml
English: In a double blind multicentre, parallel group study, enoxaparin sodium 2,000 IU (20 mg) or 4,000 IU (40 mg) once a day subcutaneously was compared to placebo in the prophylaxis of DVT in medical patients with severely restricted mobility during acute illness (defined as walking distance of <10 meters for ≤3 days).
Slovenian: V dvojno slepi, multicentrični študiji vzporednih skupin so natrijev enoksaparinat v odmerkih 2.000 i.e. (20 mg) ali 4.000 i.e. (40 mg) enkrat na dan subkutano primerjali s placebom za profilakso GVT pri nekirurških bolnikih z zelo omejeno mobilnostjo med akutno boleznijo (opredeljeno kot prehojena razdalja < 10 metrov ≤ 3 dni).
English: At doses used for prophylaxis
Slovenian: V odmerkih, ki se uporabljajo za profilakso
English: Solution for injection in multidose vial Clear, colourless to pale yellow solution.
Slovenian: raztopina za injiciranje v večodmerni viali Bistra, brezbarvna do bledo rumena raztopina.
English: • Headache.
Slovenian: • Glavobol
English: When the quantity of drug to be injected requires to be adjusted based on the patient's body weight, the graduated pre-filled syringes should be use to reach the required volume by discarding the excess before injection.
Slovenian: Če potrebna količina zdravila za injiciranje zahteva prilagoditev glede na bolnikovo telesno maso, je treba uporabiti graduirano napolnjeno injekcijsko brizgo, s katero boste potrebno količino dosegli tako, da boste pred injiciranjem zavrgli odvečno količino.
English: Inhixa 4,000 IU (40 mg)/0.4 mL
Slovenian: Inhixa 4.000 i.e. (40 mg)/0,4 ml
English: Acetylsalicylic acid is recommended for all patients without contraindications at an initial oral loading dose of 150-300 mg (in acetylsalicylic acid-naive patients) and a maintenance dose of 75-325 mg/day long-term regardless of treatment strategy.
Slovenian: Acetilsalicilna kislina je priporočljiva za vse bolnike brez kontraindikacij, in sicer v začetnem peroralnem polnilnem odmerku od 150 do 300 mg (pri bolnikih, ki še niso prejemali acetilsalicilne kisline) in v vzdrževalnem odmerku od 75 - 325 mg/dan dolgoročno, ne glede na strategijo zdravljenja.
English: Do not use Inhixa - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na natrijev enoksaparinat ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: • Inhixa can be added to the tube leaving the body (arterial line) at the start of the dialysis session.
Slovenian: • Zdravilo Inhixa se lahko na začetku dialize da v cevko, ki vodi iz telesa (v arterijsko linijo).
English: Your pre-filled syringe has a needle guard attached to it in order to protect you from needle stick injury.
Slovenian: Vaša napolnjena injekcijska igla je opremljena s spripomočkom za zaščito igle, ki služi za zaščito pred vbodom z iglo.
English: Inhixa 30,000 IU (300 mg)/3 mL
Slovenian: Inhixa 30.000 i.e. (300 mg)/3 ml
English: For the prophylaxis of venous thromboembolic disease following surgery, treatment of DVT and PE, treatment of unstable angina and NSTEMI, enoxaparin sodium should be administered by subcutaneous injection.
Slovenian: Za profilakso venske trombembolične bolezni po operaciji, za zdravljenje GVT in PE ter za zdravljenje nestabilne angine pektoris in NSTEMI je treba natrijev enoksaparinat injicirati subkutano.
English: CARTON (Packs of 2, 10 or 30)
Slovenian: ŠKATLA (pakiranja po 2, 10 ali 30)
English: Although no dose adjustment is recommended in patients with moderate (creatinine clearance 30-50 mL/min) and mild (creatinine clearance 50-80 mL/min) renal impairment, careful clinical monitoring is advised.
Slovenian: Čeprav pri bolnikih z zmerno (očistek kreatinina 30-50 ml/min) ali blago (očistek kreatinina 50-80 ml/min) okvaro ledvic odmerka ni treba prilagoditi, je priporočljivo natančno klinično spremljanje.
English: • For treatment of acute STEMI, the recommended dose of enoxaparin sodium is a single intravenous bolus of 3,000 IU (30 mg) plus a 100 IU/kg (1 mg/kg) subcutaneous dose followed by 100 IU/kg (1 mg/kg) administered subcutaneously every 12 hours (maximum 10,000 IU (100 mg) for each of the first two subcutaneous doses).
Slovenian: • Za zdravljenje akutnega STEMI je priporočeni odmerek natrijevega enoksaparinata enkraten intravenski bolus 3.000 i.e. (30 mg) in 100 i.e./kg (1 mg/kg) subkutano, nato pa 100 i.e./kg (1 mg/kg) subkutano na 12 ur (največ 10.000 i.e. (100 mg) za vsakega od prvih dveh subkutanih odmerkov).
English: • In patients at high risk of thromboembolism, the recommended dose of enoxaparin sodium is 4,000 IU (40 mg) once daily given by subcutaneous injection preferably started 12 hours before surgery.
Slovenian: • Če ima bolnik veliko tveganje za trombembolijo, je priporočeni odmerek natrijevega enoksaparinata 4.000 i.e. (40 mg) enkrat na dan v subkutani injekciji; uporaba naj se po možnosti začne 12 ur pred operacijo.
English: Each mL contains 150 mg enoxaparin sodium.
Slovenian: En ml vsebuje 150 mg natrijevega enoksaparinata.
English: For all indications except STEMI, no dose reduction is necessary in the elderly patients, unless kidney function is impaired (see below paragraph “Renal impairment” and section 4.4).
Slovenian: Starejšim bolnikom odmerka ni treba zmanjšati za nobeno indikacijo razen za STEMI; izjema so bolniki, ki imajo okvarjeno delovanje ledvic (glejte spodnji odstavek "Okvara ledvic" in poglavje 4.4).
English: In moderate risk patients, enoxaparin sodium treatment should be maintained for a minimal period of 7-10 days whatever the recovery status (e.g. mobility).
Slovenian: Pri bolnikih z zmernim tveganjem je treba zdravljenje z natrijevim enoksaparinatom nadaljevati vsaj še 7 do 10 dni, ne glede na stanje okrevanja (npr. mobilnost).
English: Inhixa 6,000 IU (60 mg)/0.6 mL
Slovenian: Inhixa 6.000 i.e. (60 mg)/0,6 ml
English: Enoxaparin sodium can be administered subcutaneously either as a once daily injection of 150 IU/kg (1.5 mg/kg) or as twice daily injections of 100 IU/kg (1 mg/kg).
Slovenian: Natrijev enoksaparinat je mogoče uporabiti v subkutani injekciji 150 i.e./kg (1,5 mg/kg) enkrat na dan ali v dveh injekcijah po 100 i.e./kg (1 mg/kg) na dan.
English: Inhixa should not be administered by the intramuscular route.
Slovenian: Zdravila Inhixa se ne sme injicirati intramuskularno.
English: Treatment of deep vein thrombosis with or without pulmonary embolism In a multicentre, parallel group study, 900 patients with acute lower extremity DVT with or without PE were randomized to an inpatient (hospital) treatment of either (i) enoxaparin sodium 150 IU/kg (1.5 mg/kg) once a day subcutaneously, (ii) enoxaparin sodium 100 IU/kg (1 mg/kg) every 12 hours subcutaneously, or (iii) heparin intravenous bolus (5,000 IU) followed by a continuous infusion (administered to achieve an aPTT of 55 to 85 seconds).
Slovenian: Zdravljenje globoke venske tromboze, s pljučno embolijo ali brez nje V multicentrični študiji vzporednih skupin so 900 bolnikov z akutno GVT spodnje okončine, s PE ali brez nje, randomizirali na bolnišnično zdravljenje (i) z natrijevim enoksaparinatom 150 i.e./kg (1,5 mg/kg) enkrat na dan subkutano, (ii) z natrijevim enoksaparinatom 100 i.e./kg (1 mg/kg) na 12 ur subkutano ali (iii) z intravenskim bolusom heparina (5.000 i.e.), ki mu je sledilo stalno infundiranje (uporabljeno tako, da je bil dosežen aPTČ od 55 do 85 sekund).
English: Wash your hands and the area that you will inject with soap and water.
Slovenian: 1) Roke in mesto injiciranja dobro umijte z milom in vodo ter jih posušite.
English: Inhixa 8,000 IU (80 mg)/0.8 mL
Slovenian: Inhixa 8.000 i.e. (80 mg)/0,8 ml
English: When given at a dose of 4,000 IU (40 mg) once a day subcutaneously, enoxaparin sodium significantly reduced the incidence of VTE as compared to placebo.
Slovenian: Natrijev enoksaparinat v odmerku 4.000 i.e. (40 mg) enkrat na dan subkutano je zmanjšal incidenco VTE značilno bolj kot placebo.
English: When non-weight adjusted dosing was administered, it was found after a single-subcutaneous 4,000 IU (40 mg) dose, that anti-Xa exposure is 52% higher in low-weight women (< 45 kg) and 27% higher in low-weight men (< 57 kg) when compared to normal weight control subjects (see section 4.4).
Slovenian: Če so uporabili odmerjanje, ki ni bilo korigirano za telesno maso, so po enkratnem subkutanem odmerku 4.000 i.e. (40 mg) ugotovili izpostavljenost anti-Xa, ki je bila pri ženskah z majhno telesno maso (< 45 kg) 52 % večja in pri moških z majhno telesno maso (< 57 kg) 27 % večja kot pri kontrolnih osebah z normalno telesno maso (glejte poglavje 4.4).
English: Enoxaparin sodium 150 IU/kg (1.5 mg/kg) once a day subcutaneously n (%)
Slovenian: Natrijev enoksaparinat 150 i.e./kg (1,5 mg/kg) enkrat na dan subkutano n (%)
English: Inhixa 2,000 IU (20 mg)/0.2 mL
Slovenian: Inhixa 2.000 i.e. (20 mg)/0,2 ml
English: If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Slovenian: Če ste noseči, domnevate, da ste noseči ali nameravate zanositi, se posvetujte z zdravnikom, preden vzamete to zdravilo.